BRIEF

on RHÖN-KLINIKUM AG (ETR:RHK)

RHÖN-KLINIKUM AG Sees Stable Q1 Growth Amidst Reforms

Stock price chart of RHÖN-KLINIKUM AG (EBR:RHK) showing fluctuations.

RHÖN-KLINIKUM AG reported stable financial growth in the first quarter of 2026. Consolidated revenue reached EUR 436.1 million, slightly surpassing Q1 2025's EUR 414.7 million. EBITDA also increased, reaching EUR 30.2 million compared to EUR 22.6 million in the previous year. Net income rose to EUR 13.1 million from EUR 7.3 million. The company treated 258,027 patients, marking a 7.4% rise in patient numbers.

The integration of Ortho Centrum Saale MVZ GmbH bolstered RHÖN-KLINIKUM's medical capabilities, focusing on orthopaedics and related fields. However, ongoing legislative changes, including the Hospital Reform Adjustment Act, pose challenges for long-term financial planning.

In anticipation of the year ahead, the company forecasts revenues of around EUR 1.7 billion, with expected EBITDA between EUR 110 million and EUR 125 million. Despite robust operational strategies, external reforms inject uncertainty into financial prospects.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all RHÖN-KLINIKUM AG news